163 related articles for article (PubMed ID: 18234965)
1. Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.
Shareef MM; Brown B; Shajahan S; Sathishkumar S; Arnold SM; Mohiuddin M; Ahmed MM; Spring PM
Mol Cancer Res; 2008 Jan; 6(1):89-98. PubMed ID: 18234965
[TBL] [Abstract][Full Text] [Related]
2. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM
Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
Chen X; Shen B; Xia L; Khaletzkiy A; Chu D; Wong JY; Li JJ
Cancer Res; 2002 Feb; 62(4):1213-21. PubMed ID: 11861406
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells.
Okamura H; Yoshida K; Sasaki E; Morimoto H; Haneji T
Int J Oncol; 2004 Oct; 25(4):1031-7. PubMed ID: 15375553
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells.
Combates NJ; Kwon PO; Rzepka RW; Cohen D
Cell Growth Differ; 1997 Feb; 8(2):213-9. PubMed ID: 9040943
[TBL] [Abstract][Full Text] [Related]
8. HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y.
Tanaka H; Ohshima N; Ikenoya M; Komori K; Katoh F; Hidaka H
Cancer Res; 2003 Oct; 63(20):6942-7. PubMed ID: 14583495
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.
Comerford KM; Wallace TJ; Karhausen J; Louis NA; Montalto MC; Colgan SP
Cancer Res; 2002 Jun; 62(12):3387-94. PubMed ID: 12067980
[TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug.
Hellin AC; Calmant P; Gielen J; Bours V; Merville MP
Oncogene; 1998 Mar; 16(9):1187-95. PubMed ID: 9528861
[TBL] [Abstract][Full Text] [Related]
14. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
15. The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53.
Strauss BE; Shivakumar C; Deb SP; Deb S; Haas M
Biochem Biophys Res Commun; 1995 Dec; 217(3):825-31. PubMed ID: 8554604
[TBL] [Abstract][Full Text] [Related]
16. The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation.
Rödel F; Schaller U; Schultze-Mosgau S; Beuscher HU; Keilholz L; Herrmann M; Voll R; Sauer R; Hildebrandt G
Strahlenther Onkol; 2004 Apr; 180(4):194-200. PubMed ID: 15057429
[TBL] [Abstract][Full Text] [Related]
17. Activation of nuclear factor kappa B in human lymphoblastoid cells by low-dose ionizing radiation.
Prasad AV; Mohan N; Chandrasekar B; Meltz ML
Radiat Res; 1994 Jun; 138(3):367-72. PubMed ID: 8184011
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG.
He B; Weber GF
Biochem Biophys Res Commun; 2004 Aug; 321(1):13-20. PubMed ID: 15358208
[TBL] [Abstract][Full Text] [Related]
19. Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma.
Friedrich RE; Punke C; Reymann A
In Vivo; 2004; 18(2):133-47. PubMed ID: 15113040
[TBL] [Abstract][Full Text] [Related]
20. Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation-induced damage.
Wang Y; Meng A; Lang H; Brown SA; Konopa JL; Kindy MS; Schmiedt RA; Thompson JS; Zhou D
Cancer Res; 2004 Sep; 64(17):6240-6. PubMed ID: 15342410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
